Cargando…
COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says
BACKGROUND: The prophylactic vaccination of COVID-19 mRNA vaccines is the first large-scale application of this kind in the human world. Over 1.8 million doses of the COVID-19 vaccine had been administered in the US until December 2020, and around 0.2% submitted AE reports to the Vaccine Adverse Eve...
Autores principales: | Chen, Gang, Li, Xiaolin, Sun, Meixing, Zhou, Yangzhong, Yin, Meifang, Zhao, Bin, Li, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177815/ https://www.ncbi.nlm.nih.gov/pubmed/34093567 http://dx.doi.org/10.3389/fimmu.2021.669010 |
Ejemplares similares
-
Acute kidney injury after COVID-19 vaccines: a real-world study
por: Luo, Huiting, et al.
Publicado: (2022) -
Association of Current Active Illnesses and Severe Acute Kidney Injury after COVID-19 Vaccines: A Real-World Study
por: Chen, Gang, et al.
Publicado: (2022) -
Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination
por: Araja, Diana, et al.
Publicado: (2022) -
Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023) -
When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice
por: Chen, Gang, et al.
Publicado: (2020)